Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pan, Ling
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3	Recruiting	4	466	RoW	Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638	The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd.	Renal Insufficiency, Chronic	10/25	03/26
TQ05105-â…¡-01, NCT05020652: A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis	Recruiting	2	105	RoW	TQ05105 tablets, Hydroxycarbamide tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Moderate and High Risk Myelofibrosis	03/23	09/23